Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Stepped Care Treatment for Binge-Eating

This study is currently recruiting participants. (see Contacts and Locations)
Verified March 2013 by Temple University
Sponsor:
Collaborator:
Information provided by (Responsible Party):
Eunice Chen, Temple University
ClinicalTrials.gov Identifier:
NCT00965705
First received: August 25, 2009
Last updated: March 19, 2013
Last verified: March 2013

August 25, 2009
March 19, 2013
June 2009
June 2013   (final data collection date for primary outcome measure)
symptom improvement [ Time Frame: 6-8 months ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00965705 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Stepped Care Treatment for Binge-Eating
Dialectical Behavior Therapy for Early Non-Responders to CBT

Temple University is looking for women to participate in a study to evaluate the treatment options available to women living with binge eating disorder.

Binge-Eating Disorder is a significant public health problem for women. Despite this, there is limited research on how best to treat this disorder at varying levels of severity. The purpose of this NIMH-funded study is to enroll individuals in a brief form of cognitive-behavior therapy. If more intense treatment is needed, individuals will be randomly assigned to more intensive group and individual treatments (Cognitive-Behavior Therapy or Dialectical Behavior Therapy). Both of these treatments are talking therapies that have been adapted for women living with binge-eating disorder and are free of charge.

Not Provided
Interventional
Not Provided
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single Blind (Subject)
Primary Purpose: Treatment
Binge Eating Disorder
Behavioral: Therapy
Individual Therapy and Group Therapy
  • Active Comparator: Guided Self Help
    Intervention: Behavioral: Therapy
  • Active Comparator: Cognitive Behavioral Therapy
    Intervention: Behavioral: Therapy
  • Active Comparator: Dialectical Behavioral Therapy
    Intervention: Behavioral: Therapy
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
100
March 2014
June 2013   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Adult female, 18 years to 60 years
  • Meets DSM-IV criteria for Binge Eating Disorder
  • Resides within commuting distance
  • Consents to research protocol, i.e.
  • 18-24 months in assessment and treatment
  • willing to be part of a biological assessment/physiological assessment
  • have to be prepared that they will receive a brief individual treatment and if this does not work for them, that they will receive more intensive treatment including both group and individual treatment.
  • agreement not to see other health professionals unless recommended
  • seeing their own Primary care Physician/Nurse Practitioner for medical screening prior to study (i.e., before being allocated a guided self-help therapist)
  • payment for their own medical assessment, monitoring, and medication if needed

Exclusion Criteria:

  • Anorexia nervosa
  • Schizophrenia, Schizophreniform, or Schizoaffective Disorders, Psychosis NOS, or Bipolar Mood Disorder
  • Needs priority treatment for other debilitating conditions, e.g. current substance dependence requiring inpatient detox
  • chronic absence of shelter
  • IQ less than 70
  • Impending jail/prison, court order to treatment, court order to treatment or to jail, or agency order to treatment or to loss of child custody (due to consequent inability to freely drop-out of treatment)
  • Is pregnant, plans to become pregnant during treatment, or becomes pregnant before random assignment to study condition
  • Medical instability
  • Has had or is seeking Gastric bypass surgery
  • On anti-seizure medication, beta-blockers, asthma medication, medication for heart disease, or any other medication that affects appetite or weight
  • Psychotropics are acceptable if the doses are stable for at least 3 months prior to screening
Female
18 Years to 60 Years
Yes
Contact: Eunice Y Chen, PhD (215) 204-2645 eunice.chen@temple.edu
United States
 
NCT00965705
20472, K23MH081030-01
Yes
Eunice Chen, Temple University
Temple University
National Institute of Mental Health (NIMH)
Principal Investigator: Eunice Y Chen, PHD Temple University
Temple University
March 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP